The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib | BMC Cancer | Full Text

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib | BMC Cancer | Full Text

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib

Chronic myeloid leukaemia is in principle a treatable malignancy but drug resistance is lowering survival. Recent drug discoveries have opened up new options for drug combinations, which is a concept used in o...

Authors:H. Jonathan G. Lindström and Ran Friedman

Citation:BMC Cancer 2020 20:397

Content type:Research Article

Published on: 7 May 2020

• ViewFull Text
 
• ViewPDF